Top 50 Biotech VC Funds & Investors in Italy (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
15 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $488k–$23M |
|
Sofinnova Partners
VC Fund
|
14 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
Indaco Venture Partners
VC Fund
|
10 | Italy, United Kingdom, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Life Science | $3.3M–$110M |
|
Italian Angels for Growth
VC Fund
|
9 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Vertis
VC Fund
|
7 | Italy, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Computer | $823k–$10M |
|
Claris Ventures
VC Fund
|
7 | Italy, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Life Science | $2.1M–$25M |
|
LIFTT
VC Fund
|
6 | Italy, United Kingdom, France | Seed, Series A | Software, Biotechnology, Manufacturing | $329k–$21M |
|
Principia SGR
VC Fund
|
6 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
Innogest Capital
VC Fund
|
5 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
UniCredit
VC Fund
|
5 | Italy, Germany, Spain | Debt Financing, Post-IPO Debt, Pre-Seed | Renewable Energy, Energy, Manufacturing | $197k–$1.4B |
|
A11 Venture
VC Fund
|
4 | Italy, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical Device, E-Commerce | $384k–$1.4M |
|
EUREKA! Venture SGR
VC Fund
|
4 | Italy | Seed, Pre-Seed | Nanotechnology, Manufacturing, Medical Device | $384k–$4.1M |
|
Green Arrow Capital
VC Fund
|
4 | Italy, United Kingdom | Seed, Series A | Health Care, Biotechnology, Manufacturing | $1.5M–$2.2M |
|
Scientifica Venture Capital
VC Fund
|
3 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $209k–$2.9M |
|
INGENIUM Emilia Romagna
VC Fund
|
3 | Italy | Seed, Angel | Medical, Health Care, Privacy | $2.1M–$2.2M |
|
Invitalia Ventures
VC Fund
|
3 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, Internet | $658k–$6.2M |
|
Club degli Investitori
VC Fund
|
3 | Italy, Switzerland, United Kingdom | Seed, Series A, Pre-Seed | Health Care, Software, E-Commerce | $197k–$30M |
|
Panakes Partners
VC Fund
|
3 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.4M–$110M |
|
Progress Tech Transfer Fund
VC Fund
|
3 | Italy, Ireland, United Kingdom | Series A, Seed | Water, Biotechnology, Manufacturing | $171k–$15M |
|
European Circular Bioeconomy Fund
VC Fund
|
3 | Germany, France, The Netherlands | Series B, Series A, Venture - Series Unknown | Biotechnology, AgTech, Agriculture | $5.9M–$43M |
|
Italian Angels for Biotech
VC Fund
|
3 | Italy | Seed, Pre-Seed | Health Care, Biotechnology, Pharmaceutical | $545k–$2M |
|
Atlante Ventures
VC Fund
|
3 | Italy, United States, Israel | Seed, Series A | Software, Biotechnology, Hardware | $150k–$3.5M |
|
Utopia
VC Fund
|
3 | Italy | Seed, Pre-Seed | Health Care, Biotechnology, Pharmaceutical | $1.4M–$2M |
|
Fondazione Cariverona
VC Fund
|
3 | Italy, Switzerland, The Netherlands | Pre-Seed, Seed | Biotechnology, Cosmetics, GreenTech | $197k–$197k |
|
Kering Ventures
VC Fund
|
3 | Italy | Series A | Biotechnology, Interior Design | $12M–$20M |
|
Lazio Innova
VC Fund
|
3 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Health Care, Software, Artificial Intelligence | $22k–$1.3M |
|
StartUp Health
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Banco BPM
VC Fund
|
2 | Italy, United States, Spain | Debt Financing, Post-IPO Debt, Pre-Seed | Manufacturing, Product Design, Renewable Energy | $544k–$878M |
|
Intesa Sanpaolo
VC Fund
|
2 | Italy, United Kingdom, United States | Debt Financing, Post-IPO Debt, Convertible Note | Energy, Manufacturing, Renewable Energy | $299k–$2.5B |
|
3B Future Health Fund
VC Fund
|
2 | United States, Italy, United Kingdom | Series B, Series A | Biotechnology, Therapeutics, Medical | $2.7M–$75M |
|
3LB Seed Capital Srl
VC Fund
|
2 | Italy, United States, United Kingdom | Seed, Pre-Seed, Series A | E-Commerce, Software, Information Technology | $71k–$2.5M |
|
Maia Ventures
VC Fund
|
2 | Italy, Belgium, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Biotechnology | $1.2M–$11M |
|
European Investment Bank
VC Fund
|
2 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$658M |
|
byFounders
VC Fund
|
2 | Denmark, United States, Sweden | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Health Care | $800k–$65M |
|
ENEA Tech e Biomedical
VC Fund
|
2 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
The Techshop
VC Fund
|
2 | Italy, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $322k–$120M |
|
XGEN Venture
VC Fund
|
2 | Italy, Sweden, Germany | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $4.6M–$141M |
|
Cube Labs
VC Fund
|
1 | Italy | Corporate Round | Wellness, Health Care, Biotechnology | |
|
Launch Tennessee
VC Fund
|
1 | United States, China, Italy | Grant, Seed, Series A | Software, Health Care, Medical | |
|
Exor Ventures
VC Fund
|
1 | United States, Italy, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, FinTech | |
|
Sparta Capital
VC Fund
|
1 | Italy, Germany | Series A, Series B | Solar, Life Science, Biotechnology | |
|
Embed Capital
VC Fund
|
1 | Italy, Switzerland, United Kingdom | Seed, Pre-Seed | Information Technology, Health Care, Mobile | |
|
Forbion Capital Partners
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | |
|
Crédit Agricole Italia
VC Fund
|
1 | Italy | Debt Financing, Seed | Financial Services, Finance, Water | |
|
Vento
VC Fund
|
1 | Italy, Germany, Switzerland | Pre-Seed, Seed, Angel | Software, Artificial Intelligence, SaaS | |
|
Spindial Group
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
United Ventures
VC Fund
|
1 | Italy, United States, United Kingdom | Series A, Seed | Software, FinTech, Information Technology | |
|
Longwood Fund
VC Fund
|
1 | United States, United Kingdom, Italy | Series A, Series B, Series C | Biotechnology, Therapeutics, Health Care | |
|
Angels4Women
VC Fund
|
1 | Italy, United States | Seed, Angel | Retail, Fashion, Lingerie | |
|
Schia Ventures
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
| Access all 203 VC funds in Italy Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 277
- Round size: Seed $488k–$8.1M; Series A $3.3M–$23M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- Klaaryo —
- Macingo — Trasporto, spedizioni e traslochi a basso costo. Trasporti economici di auto, moto, barche e mobili in Italia ed Europa. Confronta prezzi e risparmia il 70%
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 319
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Series C
- Geography: Italy, United Kingdom, Switzerland
Investor stats
- Total investments: 47
- Round size: Series A $3.3M–$31M; Series B $8.8M–$89M; Series C $16M–$110M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 104
- Round size: Seed $329k–$5.9M; Angel $219k–$1.2M; Series A $2.7M–$14M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
- AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
- Alomana —
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more...Investment focus
- Industry: Software, Biotechnology, Computer
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 68
- Round size: Seed $823k–$3.7M; Series A $1.5M–$10M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- Quido AI — Quido is the co-pilot for investment professionals. Quido allows private capital professionals to streamline data retrieval and data analysis and dramatically increase their efficiency.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Series A, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $2.1M–$11M; Series A $6.1M–$25M; Series B $7.4M–$20M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Lever Bio — Lever Bio's vision is to be at the forefront of unlocking groundbreaking advancements in biotech, particularly in the field of immuno-oncology. By fostering strategic collaborations with leading researchers, prestigious universities, and innovative research centers, Lever Bio aims to accelerate the development of cutting-edge therapies andtechnologies
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
- Haptena Therapeutics — Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Seed $329k–$7.6M; Series A $2.7M–$21M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Prestiamoci — Prestiamoci is the first community of loans between individuals born in Italy, allowing you to make profitable investment and to obtain loans with installments transparent.With Prestiamoci the providers invest and get Claimants, returning to its original role of the bank safe. Loans shall be paid by people to trustworthy people who want toachieve their life projects, grow their professional activity, better manage expenses and major purchases
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Manufacturing
- Stage:Debt Financing, Post-IPO Debt, Pre-Seed
- Geography: Italy, Germany, Spain
Investor stats
- Total investments: 138
- Round size: Pre-Seed $197k–$197k; Post-IPO Debt $38M–$1.4B; Debt Financing $521k–$938M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Banxware — Banxware provides the technology and the funds for business financing of any kind: fully embedded in your platform or as an affiliate solution - all managed by Banxware
- Ivpc Group — Ivpc Group is a renewable energy company that specializes in the development and management of wind farms and turbines.
- Mercuria — A world leading independent energy and commodity group
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States
Investor stats
- Total investments: 14
- Round size: Seed $384k–$1.4M; Pre-Seed $734k–$1.1M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- AdapTronics — AdapTronics is a deep-tech startup that produces adaptive mechatronic devices to make logistics sustainable on Earth and in space. Its adaptive mechatronics technology offers an alternative based on a multifunctional electrostatic membrane that allows the gripping and manipulation of objects of any shape. In addition, it offers a thin-filmtechnology with sensor capabilities that becomes adhesive when electrically activated.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more...Investment focus
- Industry: Nanotechnology, Manufacturing, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 37
- Round size: Seed $384k–$4.1M; Pre-Seed $3M–$3M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Caracol — Lead the future of manufacturing thanks to Caracol's 3D printing technologies. Discover our solutions for industrial, Large Format Additive Manufacturing.
- EYE4NIR — EYE4NIR is a information technology company that develops visible and SWIR image sensors with help of innovative technologies.
- Novac — Progettiamo supercondensatori da affiancare alle batterie, per incrementare performance ed efficienza dei veicoli elettrici.
Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 9
- Round size: Series A $1.5M–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
- Maticmind S.p.A — Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators.
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 16
- Round size: Seed $209k–$2.9M; Pre-Seed $209k–$541k
- Lead/follow: 75% lead, 25% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Privacy
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2.1M–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, Internet
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 110
- Round size: Seed $197k–$8.2M; Pre-Seed $614k–$5.1M; Series A $889k–$30M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- CiaoDott —
- Quantum Bridge — Quantum Bridge is a pioneer in Distributed Symmetric Key Exchange (DSKE) technology. It offers quantum-safe cybersecurity products and services. Quantum-safe product and services, Quantum-safe roadmap and quantum-safe solutions implementation.
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $4.4M–$79M; Series B $9.9M–$60M; Series C $18M–$110M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
Investment fund specialized in sustainable technologies from universities and public research organizations, start-ups, spin-offs, and entrepreneurs.
Show more...Investment focus
- Industry: Water, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: Italy, Ireland, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $171k–$1.6M; Series A $9.9M–$15M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- WembraneX — WembraneX's goal is to make wastewater treatment facilities more cost-effective by introducing a new class of anti-fouling and anti-biofouling membranes.
- Naturbeads — Naturbeads creates biodegradable, sustainable and cost competitive cellulose microbeads to replace currently used microplastics.
- Valuematic — Valuematic realizza soluzioni per il trattamento e gestione dei dati favorendo il miglioramento nei processi organizzativi e informativi di aziende ed enti.
The specialist VC for a regenerative economy
Show more...Investment focus
- Industry: Biotechnology, AgTech, Agriculture
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: Germany, France, The Netherlands
Investor stats
- Total investments: 29
- Round size: Series A $5.9M–$19M; Series B $11M–$43M; Venture - Series Unknown $8.7M–$20M
- Lead/follow: 66% lead, 34% follow
- Last fund: Likely still investing — raised $351M in 2022
Portfolio highlights
- Reduced — Reduced develops natural flavor enhancers from upcycled produce.
- Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
- foodforecast — AI supported solution to reduce food waste.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Angel group focuses on biotech
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $545k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Show more...Investment focus
- Industry: Software, Biotechnology, Hardware
- Stage:Seed, Series A
- Geography: Italy, United States, Israel
Investor stats
- Total investments: 46
- Round size: Seed $150k–$3.5M; Series A $1.5M–$3.3M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2007
Portfolio highlights
- ADmantX — A NEW ERA OF AUDIENCE TARGETINGADmantX is a contextual analysis and data provider that brings audience targeting to a new level. Awarded patent for semantic advertising technology, the company offers a cookie-less solution that allows publishers, ad networks and exchanges, brand managers and agencies to develop more effective online adcampaigns leveraging semantic understanding, natural language processing and sentiment analysis. Founded in Italy as a spin-off of the leading semantic company Expert System, ADmantX is active in Europe and US. Worldwide customers include NBCUniversal, Integral Ad Science, Networked Insights, Banzai, Cadreon, Amnet, Sojern, Media IQ and ADmantX solutions are integrated in key DSP players such as Turn, Adform and AppNexus.
- YOGITECH — Notizie e approfondimenti di Tecnologia
- Expert.ai — Expert.ai is the premier artificial intelligence platform for language understanding.
Utopia is a venture capital firm that is dedicated to life sciences.Utopia SIS is an investment company specializing in healthcare and biomedical research, promoted and owned by the Golinelli Foundation.Utopia was established with the aim of bridging this gap, through investments in high-potential start-ups operating in the Life Sciencessector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Round size: Seed $1.4M–$2M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Fondazione Cariverona. Da oltre 25 anni per lo sviluppo civile, culturale ed economico di Verona, Vicenza, Belluno, Ancona e Mantova.
Show more...Investment focus
- Industry: Biotechnology, Cosmetics, GreenTech
- Stage:Pre-Seed, Seed
- Geography: Italy, Switzerland, The Netherlands
Investor stats
- Total investments: 8
- Round size: Pre-Seed $197k–$197k
- Lead/follow: 88% lead, 12% follow
Portfolio highlights
- Kymia — Kymia provides products like face powder, concealer, lip gloss, eye makeup and accessories make use of natural ingredients thoroughly enabling customers to benefit from healthy and effective beauty products
- Noiet — Noiet is a biotechnology firm whose mission is to develop clean, natural, and fermented proteins that serve as multifunctional alternatives.
- Alma Serum — Alma Serum is a cosmetic and biotech company that turns dairy industry into advanced cosmetic and biomedical materials.
Kering Ventures is the venture investment arm of the Kering Group, acquiring minority holdings in startups.
Show more...Investment focus
- Industry: Biotechnology, Interior Design
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Series A $12M–$20M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
- SQIM — SQIM is a biotechnological based agency.
- Superplastic — Superplastic is a character-based product and entertainment company. It creates limited edition art toys, apparel, games, and animation based on characters created in collaboration with some of the greatest artists in the world. Superplastic is founded on the principle that effort and scarcity are intrinsic components of value. The companyappropriates the tools of mass media and mass production to create limited edition works of art for a limited audience. It was established in 2017 and is based in Burlington, Vermont.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 27
- Round size: Seed $186k–$1.3M; Grant $22k–$409k; Pre-Seed $53k–$549k
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- HEU — HEU is a legaltech company that automates and manages legal documents and allows users to edit and share them.
- Tech4All — We support the study by using AI.
- GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 195
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Scopri i servizi bancari e finanziari di Banco BPM: conti, mutui, carte, prestiti, assicurazioni, trading e tanto altro. Per privati e imprese.
Show more...Investment focus
- Industry: Manufacturing, Product Design, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Pre-Seed
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 53
- Round size: Post-IPO Debt $8.7M–$878M; Debt Financing $544k–$609M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- ESAPRO — ESAPRO designs, constructs, and manages plants for the production of electricity from renewable sources.
- Enex — Enex specializes in designing, developing, and manufacturing heating, refrigeration, and air conditioning systems.
- Pharma Green Holding — Pharma Green Holding is a company that aims to create a unified and advanced pharmacy network that delivers healthcare solutions.
Intesa Sanpaolo is a banking group that specializes in wealth management, protection, advisory, and digital orientation. Their products and services include accounts, cards, loans, mortgages, insurance, digital payments, retirement planning, investments, and consulting. It was founded by the merger of Banca Intesa and Sanpaolo IMI.
Show more...Investment focus
- Industry: Energy, Manufacturing, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Convertible Note
- Geography: Italy, United Kingdom, United States
Investor stats
- Total investments: 141
- Round size: Post-IPO Debt $112M–$2.5B; Debt Financing $1.1M–$1000M; Convertible Note $299k–$2.2M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- ESAPRO — ESAPRO designs, constructs, and manages plants for the production of electricity from renewable sources.
- Cornaglia — Cornaglia designs, develops, and manufactures metal and plastic components for the automotive industry.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series B, Series A
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 36
- Round size: Series A $2.7M–$43M; Series B $7.4M–$75M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!3LB Seed Capital is not an alternative to start-ups incubators and accelerators, rather acts as a complementary reality that helps to enhance your project in terms of attractiveness for the investor and venture capital market.As investors they are the first willing to know if your project has what it takes to grow successfully. If they areconvinced of your potential, they are ready to bet on you, by joining you and helping you to develop your project.3LB Seed Capital does not provide a percentage of equity in exchange for accompanying activities, but relies exclusively on a premium at the time of its first direct investment in your company.
Show more...Investment focus
- Industry: E-Commerce, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 21
- Round size: Seed $71k–$2.5M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- YoAgents — Yo Agents nasce dalla unione delle competenze di ogni singolo founder messe a fattor comune per creare un sales hub innovativo.
- Botsociety — Your conversational design suite. Design and prototype your next chatbot or voice assistant. Create a mockup of your project on Messenger, Slack, Google Assistant, Alexa and more. The next generation design solution for chatbots and voice.
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Seeding change by investing in category-defining agri & foodtech ventures.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Belgium, United Kingdom
Investor stats
- Total investments: 9
- Round size: Seed $1.2M–$11M; Pre-Seed $1.2M–$3.6M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- Sintropy — Sintropy develops AI and IoT-based solutions that optimize energy consumption and building operations. The company offers a Physical AI platform for retail, foodservice, and industrial customers that connects proprietary sensors with automation systems. Its technology uses sensor data to control HVAC and related equipment, with a focus onmeasurable energy savings. Sintropy designs and manufactures its own IoT sensors and integrates robotics and AI to capture operational data. Customers use the platform to monitor conditions, automate climate control, and improve the efficiency of physical spaces.
- Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
- Foreverland — Foreverland Food is an Italian food-tech startup.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 360
- Round size: Post-IPO Debt $18M–$658M; Debt Financing $16M–$384M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Affibody — Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a largenumber of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.
- RE:OCEAN — OUR MISSION IS TO FARM SALMON FOR THE BENEFIT OF HEALTH AND THE PLANET. WE'LL DO THIS BY BUILDING A LARGE SCALE FISH FARM IN THE middle OF SWEDEN. - WE'RE MAKING THE IMPOSSIBLE POSSIBLE - AN OCEAN ON LAND. RE:OCEAN IN BRIEF One in five salmons in Sweden 2026 will come from RE:OCEAN Fresh
- Metso Outotec —
byFounders is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries. With its unique Collective of founders and operators, byFounders offers its portfolio operational expertise and a global network. Believing in the power of tech to shape our future, byFounders takes an impact-aware approach to investing and working with the broader startup ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, United States, Sweden
Investor stats
- Total investments: 114
- Round size: Seed $1.5M–$9.4M; Pre-Seed $800k–$4.2M; Series A $6.1M–$65M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely still investing — raised $117M in 2021
Portfolio highlights
- Flare — Flare builds infrastructure for a more internet by connecting real-world data with machine learning in a verifiable way.This combines human intelligence with advanced AI to improve the clarity and reliability of information.Its goal is to create a shared, high-quality knowledge foundation that helps people navigate information with confidence.
- Verda (formerly DataCrunch) — DataCrunch is a cloud service provider which facilitates utilization and integration of state of the art AI/ML models
- Spiral Hydrogen — Spiral Hydrogen's mission is to lower the price of green hydrogen below that of fossil hydrogen, so opening up an industry for decarbonization and making hydrogen transportation and heating commercially viable.
ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Health Triage — Health Triage researches, designs, and develops clinical data, new technologies, and applications for the health sector. Their research activities focus on the development of new screening protocols and innovative diagnosis processes, exploiting deep learning to facilitate the acquisition of new technologies through data learned from algorithms andneural networks.
The Techshop is a venture capital and private equity firm that invests in B2B digital startups.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 25
- Round size: Seed $658k–$8.2M; Pre-Seed $322k–$37M; Series A $8.2M–$120M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Qodeup — Qodeup is a provider of digital menu solutions for restaurants. Their QR code payment method reduces waiting times to zero for customers, increases turnover, and is eco-friendly. They allow customers to pay the bill directly from their smartphone through their QR code payment system.
- Octostar — Octostar is the AI-powered investigative intelligence platform for law enforcement, national security, and financial institutions. Connect the dots and discover the facts across petabytes of data.
- Sustainable Brand Platform — Sustainable Brand Platform is the sustainability intelligence solution for fashion brands and manufacturers to accurately measure and manage their sustainability performance.
XGEN Venture is an Italian alternative investment fund manager (Società di Gestione del Risparmio, or SGR) with over 15 years of experience in the startup process and the development of innovative solutions for high unmet medical needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: Italy, Sweden, Germany
Investor stats
- Total investments: 8
- Round size: Series A $11M–$98M; Series B $4.6M–$141M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- EpilepsyGTx — EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE).
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
We enable innovation
Show more...Investment focus
- Industry: Wellness, Health Care, Biotechnology
- Stage:Corporate Round
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Adamas Biotech — More than a decade of basic research in the field of botanical function-specific antioxidants. The nutraceutical solutions proposed to stem from a patented protected technology.
Launch Tennessee provides startup resources to entrepreneurs, including capital sources, mentorship, accelerators, entrepreneurship training and more
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Grant, Seed, Series A
- Geography: United States, China, Italy
Investor stats
- Total investments: 113
- Lead/follow: no public data
Portfolio highlights
- DAXOR — DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential totransform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
- Preteckt — Preteckt's AI software predicts & prevents breakdowns in buses & coaches. Reduce costs, maximize uptime, & extend vehicle life
- Daily Crunch — Daily Crunch is an offline and online store that offers cherry-berry nuts, cacao sea salt, and sprouted almonds products.
Exor Ventures is the venture capital arm of Exor, one of Europe's largest diversified holding companies. Exor Ventures focuses on early and growth-stage investments in technology-driven companies across various sectors, including digital services, fintech, cybersecurity, and mobility. Exor Ventures leverages its strategic insights and globalnetwork to identify promising startups with disruptive potential and supports them through funding, mentorship, and access to its extensive resources. EXOR Seeds offers a truly different type of partnership to the select group of entrepreneurs that it backs:- As a fifth-generation family-led business, we proved that we are builders not traders;- Our permanent capital allows us to take a long-term view and put the interest of the companies We invest in first;- Our global network, across industries and geographies, is a unique advantage to entrepreneurs
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 127
- Lead/follow: no public data
Portfolio highlights
- N5 Now — N5 has developed the way out of your complex legacy systems and into the fintech digital world, without having to change your core technology. Contact Us!
- PhaseV — PhaseV empowers biopharma sponsors and CROs with AI/ML-driven solutions for fast, efficient, and accurate clinical development decisions.
- Byzantine Finance — Stake assets, secure other services, and earn more. Restake now with Byzantine Finance to become part of DeFi's next generation. Building the most secure and profitable future for staking.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sparta Capital Ltd. focuses on product development, manufacturing, distribution, sales and service across a range of technologies. The Company's offering includes four different market verticals: transportation, mining, construction and energy (through biomass conversion). These offerings include optimization of energy consumption in thecommercial and manufacturing sectors, construction and energy through biomass conversion, energy conservation in mining, and energy savings in transportation. It is focused on the expansion of a range of divisions, including photoluminescent safety products division, energy audit (EMD) division, biomass division and mining division.
Show more...Investment focus
- Industry: Solar, Life Science, Biotechnology
- Stage:Series A, Series B
- Geography: Italy, Germany
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Sunvigo — Sunvigo provides you with cheap solar power from your roof and real green power from the grid.
- GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid derivatives at commercial scale directly from biomass.
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more...Investment focus
- Industry: Information Technology, Health Care, Mobile
- Stage:Seed, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 17
- Lead/follow: no public data
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 152
- Lead/follow: no public data
Portfolio highlights
- Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
- Eeden — Eeden engages in the manufacture and supply of textiles.
- Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
Crédit Agricole Italia is a bank that offers loans and financial services.
Show more...Investment focus
- Industry: Financial Services, Finance, Water
- Stage:Debt Financing, Seed
- Geography: Italy
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- Ogyre —
- FoolFarm — UN NUOVO MODO DI CREARE STARTUP Investiamo in imprenditori con idee rivoluzionarie in AI e Deep-tech. Offriamo supporto operativo ed investimenti per costruire aziende leader attraverso un metodo validato ed un team esperto in startup. CANDIDA LA TUA IDEA DIVENT
- Krill Design — Krill Design is a design studio that creates circular economy projects to convert organic waste into material resources. It is a patented process that intercepts resources from the food supply chain to create zero-impact eco-designed 3D printed products.
We want to empower the next generation of exceptional Italian founders by investing in and building new companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Pre-Seed, Seed, Angel
- Geography: Italy, Germany, Switzerland
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Tundr — Tundr offers smartcard to companies for sustainable mobility.
- Lexroom.ai — Lexroom.ai allows lawyers to complete hours of legal research in seconds.Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters.Lexroom.ai perfectly integrateswith lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities.Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
- ReportAId — ReportAId is an AI-powered software that breathes life into medical reports to make healthcare more organized, customized, and accessible.
Spindial Group
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
We are an independent Venture Capitalfirm supporting visionary entrepreneurs toreinvent industries through technology.
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 69
- Lead/follow: no public data
Portfolio highlights
- xFarm Technologies — The agricultural business is becoming more and more complex due to legal requirements and product certification. On the other hand, technologies evolve and create opportunity. xFarm is a startup that aims at the digitization of agriculture, providing innovative tools that can support farmers and food supply chain's stakeholders in themanagement of their companies. Created by farmers and tailored to the agricultural sector, its main focus is on ease of use, intuitiveness and complete adaptability to agricultural realities. The digital ecosystem includes a free agricultural application, available on both mobile and desktop and integrated with advanced premium modules, a dashboard Analytics dedicated to professionals and a line of IoT sensors selected, optimized and connected by xFarm.
- Stema — It serves as a platform for hiring engineers
- Volume — Payment Infrastructure for the Internet
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Italy
Investor stats
- Total investments: 64
- Lead/follow: no public data
Portfolio highlights
- Pulmocide — Pulmocide is developing novel inhaled medicines for serious respiratory diseases
- Newleos Therapeutics — Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Angels4Women is a company that invests in business startups lead by females.
Show more...Investment focus
- Industry: Retail, Fashion, Lingerie
- Stage:Seed, Angel
- Geography: Italy, United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
- FUTURELY — FUTURELY is a platform which will help to choose university.
- Chite Milano — Lingerie the Italian way. Discover 100% Made in Italy lingerie. Make your own: customise your lingerie and nightwear.
Schia Ventures is investment firm.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Biotech VC funding in Italy at a glance
Stats across 208 deals from 203 investors.
Access all 203 VC funds in Italy Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 203 VC funds investing in Italy Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!